Tralokinumab in Atopic Dermatitis: A Profile of Its Use
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-022-01135-9
Abstract: Tralokinumab (tralokinumab-ldrm) [Adbry™ (USA); Adtralza® (EU)], a human IgG4 monoclonal antibody that binds specifically to interleukin (IL)-13, is an effective and generally well tolerated treatment option for adult patients with moderate to severe atopic dermatitis… read more here.
Keywords: atopic dermatitis; moderate severe; profile; tralokinumab ... See more keywords
Review of Tralokinumab in the Treatment of Atopic Dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221105686
Abstract: Objective To review pharmacokinetics, efficacy, and safety of tralokinumab in treatment of atopic dermatitis (AD). Data Sources Literature review was conducted using MEDLINE (PubMed), EMBASE, and ClinicalTrials.gov for articles published between January 2010 and May… read more here.
Keywords: tralokinumab; review; treatment atopic; atopic dermatitis ... See more keywords